For over 40 years, Sorin Group has been first to introduce technologies that have helped to shape the heart valve industry. We invite you to explore this section to learn more about those innovations, and take a look at the latest technologies poised to improve cardiac patient outcomes now and in the future.
Sorin Group continues to invest significantly in technological innovation internally and externally for sustainable long-term growth. In fact, the company increased its annual investment in research and development to nearly 8% of sales. We believe that this ongoing commitment to innovation is the foundation for making Sorin Group the choice of cardiac surgeons worldwide.